• ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Average Rating of "Buy" from Brokerages

    ソース: Buzz FX / 09 10 2024 02:01:11   America/Chicago


    ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Average Rating of "Buy" from Brokerages Written by MarketBeat October 9, 2024 Share Link copied to clipboard. ARS Pharmaceuticals, Inc. ( NASDAQ:SPRY - Get Free Report ) has been assigned an
    Read more...
シェアする